ACS OmegaPharmacology & ToxicologyPeer-reviewed journal article
Tackling Anticancer Drug Resistance and Endosomal Escape in Aggressive Brain Tumors Using Bioelectronics
Akhil JainiD, Philippa WadeiD, Snow StolnikiD, Alistair N. HumeiD, Ian Derek KerriD, Beth CoyleiD, Frankie James RawsoniD
Abstract
Chemotherapy resistance and endosomal entrapment, controlled by intracellular trafficking processes, are major factor in treatment failure. Here, we test the hypothesis that external electrical stimulus can be used to modulate intracellular trafficking of chemotherapeutic drugs in most common malignant brain tumors in childhood (medulloblastoma) and gold nanoparticles (GNPs) in adulthood (glioblastoma). We demonstrate that application of alternating current (AC) with frequencies ranging from KHz-MHz and low strength (1 V/cm) lead to killing of cisplatin and vincristine resistant (mediated by extracellular vesicles) medulloblastoma cell lines. On the other hand, in primary glioblastoma cells high frequency AC (MHz) regulated the endosomal escape of GNPs. No significant effect on the viability of the control medulloblastoma cells (resistant cells cultured in drug free media and non-resistant cells) and glioblastoma cells after AC treatment confirmed targeting of intracellular trafficking process. This work supports future application of AC in drug delivery and brain cancer therapy.
- Citations
- 6
- FWCI
- 0.50
- Field percentile
- 48th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Electric Field Responsive Nanotransducers for Glioblastoma
A. Jain, I. Jobson, … F. J. Rawson·Bioelectronic MedicinePeer-reviewed·Oct 19, 2022
- Bioelectronic Modulation of Glioblastoma via Wireless Carbon Nanotube Porin Interfaces
Fleur E Groualle, David Onion, … Frankie James Rawson·bioRxiv·Jul 4, 2025
- Circumventing drug treatment? Polyethylenimine functionalized nanoparticles inherently and selectively kill patient-derived glioblastoma stem cells
N. Prabhakar, J. Merisaari, … J. Rosenholm·bioRxiv·Dec 14, 2020
- PLGA-based dual-loaded nanoformulation of DIM and TMZ - An advanced clinical strategy for brain cancer treatment in a combinatorial approach
S. Sarkar, S. Kumar, … M. K. Ghosh·bioRxiv·May 4, 2023
- On-demand, reversible blood-brain barrier opening via electrical activation of piezoelectric nanoparticles for targeted brain drug delivery
Salona Roy, Umisha Siwakoti, … Qi Cai·bioRxiv·Jul 22, 2026
- Intraventricular infusion to circumvent the blood-brain barrier to gemcitabine.
Bruno Chauffert, Antoine Galmiche, … Jacques Beaurain·bioRxiv·May 5, 2026